23andMe's Data Dilemma: What Happens to Your Genetic Information If the Company Fails?
As 23andMe faces financial turbulence with its stock plummeting over 90% since going public in 2021, serious questions are emerging about the fate of millions of customers’ genetic data. The company, which has collected DNA samples from approximately 14 million people, is now confronting the possibility of bankruptcy or acquisition, raising critical concerns about data privacy and security. While 23andMe maintains that customer genetic information would be protected even in bankruptcy proceedings, privacy experts remain skeptical about these assurances.
Continue reading